...
首页> 外文期刊>Journal of Clinical Microbiology >Rapid Multiplexed Immunoassay for Simultaneous Serodiagnosis of HIV-1 and Coinfections
【24h】

Rapid Multiplexed Immunoassay for Simultaneous Serodiagnosis of HIV-1 and Coinfections

机译:快速多重免疫测定可同时进行HIV-1和合并感染的血清学诊断。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Diagnosis of opportunistic infections in HIV-infected individuals remains a major public health challenge, particularly in resource-limited settings. Here, we describe a rapid diagnostic system that delivers a panel of serologic immunoassay results using a single drop of blood, serum, or plasma. The system consists of disposable cartridges and a simple reader instrument, based on an innovative implementation of planar waveguide imaging technology. The cartridge incorporates a microarray of recombinant antigens and antibody controls in a fluidic channel, providing multiple parallel fluorescence immunoassay results for a single sample. This study demonstrates system performance by delivering antibody (Ab) reactivity results simultaneously for multiple antigens of HIV-1, Treponema pallidum (syphilis), and hepatitis C virus (HCV) in a collection of clinical serum, plasma, and whole-blood samples. By plotting antibody reactivity (fluorescence intensity) for known positive and negative samples, empirical reactivity cutoff values were defined. The HIV-1 assay shows 100% agreement with known seroreactivity for a collection of 82 HIV Ab-positive and 142 HIV Ab-negative samples, including multiple samples with HCV and syphilis coinfection. The treponema-specific syphilis assay correctly identifies 67 of 68 T. pallidum Ab-positive and 100 of 102 T. pallidum Ab-negative samples, and the HCV assay correctly identifies 59 of 60 HCV Ab-positive and 120 of 121 HCV Ab-negative samples. Multiplexed assay performance for whole-blood samples is also demonstrated. The ability to diagnose HIV and opportunistic infections simultaneously at the point of care should lead to more effective therapy decisions and improved linkage to care.
机译:在艾滋病毒感染者中诊断机会性感染仍然是主要的公共卫生挑战,尤其是在资源有限的环境中。在这里,我们描述了一种快速诊断系统,可以使用一滴血液,血清或血浆来提供一组血清学免疫测定结果。该系统基于平面波导成像技术的创新实现,由一次性墨盒和简单的读取器仪器组成。该药盒在流体通道中整合了重组抗原和抗体对照的微阵列,可为单个样品提供多个平行的荧光免疫测定结果。这项研究通过在临床血清,血浆和全血样本中同时针对HIV-1,梅毒螺旋体(梅毒)和丙型肝炎病毒(HCV)的多种抗原同时提供抗体(Ab)反应性结果来证明系统性能。通过绘制已知阳性和阴性样品的抗体反应性(荧光强度),可以确定经验性反应性截止值。 HIV-1检测显示82种HIV Ab阳性和142 HIV Ab阴性样品(包括多个带有HCV和梅毒合并感染的样品)的已知血清反应性100%一致。梅毒螺旋体特异性梅毒检测可正确识别68例梅毒螺旋体Ab阳性样品中的67例,以及102例梅毒螺旋体Ab阴性样品中100例,并且HCV检测可正确识别60例HCV Ab阳性和59例121例HCV Ab阴性样品。还显示了对全血样品的多重分析性能。在护理时同时诊断艾滋病毒和机会性感染的能力应导致更有效的治疗决策并改善与护理的联系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号